Clinical Evaluation of Anticancer Treatments: Phase II Clinical Trials-Reference-Cited by-同舟云学术

Clinical Evaluation of Anticancer Treatments: Phase II Clinical Trials

Published:1987 Issue: Volume: Page:175-197
ISSN:
Container-title:Clinical Evaluation of Antitumor Therapy
language:
Short-container-title:

Author:

Scher Howard I.,Geller Nancy L.,Muggia Franco M.,Rozencweig Marcel

Publisher

Springer US

Link

http://link.springer.com/content/pdf/10.1007/978-1-4613-2317-4_9

Reference79 articles.

1. Devita V, Oliverio V, Muggia F, et al. The drug development and clinical trials program of the Division of Cancer Treatment, National Cancer Institute. Cancer Clin Trials 2: 195, 1979.

2. Venditti J. Preclinical drug development: Rationale and methods. Sem Oncol 8: 349, 1981.

3. Von Hoff D, Coltman C, Forseth B. Activity of 9,10-anthracenedicarboxyaldehyde bis(4,5 dihydro-1 H-imidazol-2-yl)hydrazone dihydrochloride (CL 216,942) in a human tumor cloning system: Leads for phase II trials in man. Cancer Chemother Pharm 6: 141, 1981.

4. Scher H, Schwartz S, Yagoda A, et al. Phase II trial of bisantrene for advanced hypernephroma. Cancer Treat Rep 66: 1653, 1982.

5. Rozencweig M, Von Hoff D, Staquet M. New anticancer drugs: Mitoxantrone and bisantrene. EORTC Trials. New York: Raven Press, 1984, p. 194.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stadiengerechte Chemotherapie des Magenkarzinoms;Der Magen;1993

2. Stage-Adjusted Chemotherapy of Gastric Cancer;The Stomach;1993

3. Design of Phase I and II Trials in Cancer;Drug Information Journal;1990-04

4. Chemotherapie des Oesophaguskarzinoms;Aktuelle Therapie des Oesophaguskarzinoms;1990

5. Neue Aspekte in der Chemotherapie des fortgeschrittenen Magenkarzinoms;Aktuelle Therapie des Kardiakarzinoms;1988